Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

A Comparison of Oscillatory Potential Isolation Techniques and the Functional Protection of Topical 0.3% Nepafenac in the Streptozotocin Induced Model of Diabetes

J.A. Jamison; S. Ball; C. Miller; T.S. Kern; D.P. Bingaman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1675.

ARVO Annual Meeting Abstract May 2006

Critical Role of iNOS in Pathogenesis of Early Stages of Diabetic Retinopathy

L. Zheng; Y. Du; C. Miller; R. Gubitosi–Klug; B.A. Berkowitz; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1712.

ARVO Annual Meeting Abstract May 2006

Inhibition of Interleukin–1ß Signaling Prevents Diabetes–Induced Formation of Acellular Capillaries in the Retina of Mice

S. Mohr; T.S. Kern; J.A. Vincent

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1717.

ARVO Annual Meeting Abstract May 2005

Pro–inflammatory Changes in Blood Plasma and Retinal Fatty Acid Profiles in Streptozotocin (STZ) Diabetic Rats

W.J. Esselman; W. Chen; T.S. Kern; D.B. Jump; J.V. Busik

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):398.

ARVO Annual Meeting Abstract May 2005

Eicosanoids as Mediators of Inflammation in Diabetic Retinopathy

R.A. Gubitosi–Klug; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):425.

ARVO Annual Meeting Abstract May 2005

Topical Administration of Nepafenac Inhibits the Early Stages of Diabetic Retinopathy

T.S. Kern; C. Miller; Y.P. Du; L. Zheng; S. Mohr; S. Ball; D.P. Bingaman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4703.

ARVO Annual Meeting Abstract May 2004

Inhibition of PARP inhibits development of early stages of diabetic retinopathy

T.S. Kern; L. Zheng; C. Szabo

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1096.

ARVO Annual Meeting Abstract May 2004

Using C57BL/6J as a mouse model for diabetic retinopathy

R. Feit; R. Kinouchi; T.S. Kern; D.F. Chen

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3253.

ARVO Annual Meeting Abstract May 2003

Long-term Leukocyte-mediated Vascular Pathology in the Diabetic Retina

A.M. Joussen; V. Poulaki; M.L. Le; K. Koizumi; C. Esser; H. Janicki; S. Fauser; T.S. Kern; B. Kirchhof; A.P. Adamis

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3291.

ARVO Annual Meeting Abstract May 2003

Microarray Analysis of Mouse Models of Diabetic Retinopathy Reveals Dramatic Modulation of Crystallin Genes in the Retina

R. Farjo; T.S. Kern; U.P. Andley; A. Swaroop

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3297.

ARVO Annual Meeting Abstract May 2003

Captopril Inhibits Retinal Glucose Accumulation and High Glucose-induced Increase in Glucose Transport in Retinal Endothelial Cells

J. Zhang; M. Widness; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3570.

ARVO Annual Meeting Abstract May 2003

Minocycline Prevents Hyperglycemia-Induced Caspase Activation in Retina of Diabetic Mice and in Retinal Müller Cells

S. Mohr; C. Miller; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3875.

ARVO Annual Meeting Abstract May 2003

Effects of High Dose Insulin Eye Drops on the Development of Diabetic Retinopathy in Rats

S.B. Koevary; J. Nussey; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3892.

ARVO Annual Meeting Abstract May 2003

Topical Nepafenac: Effects on Diabetes-Induced Increases in Retinal Leukostasis and Superoxide Production

L. Zheng; Y. Du; C. Miller; D.P. Bingaman; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3899.

ARVO Annual Meeting Abstract May 2003

Identification of Retinal Proteins that are Nitrated in Elevated Glucose Concentration

Y. Du; M. Miyagi; K. West; J.W. Crabb; T.S. Kern

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3901.

Advertisement